4-BMC (4-bromomethcathinone), also known as Brephedrone or para-bromomethcathinone, is a synthetic cathinone stimulant — a member of the beta-keto amphetamine class that includes mephedrone, methylone, and related compounds. The para-bromo substitution on the phenyl ring distinguishes it structurally from other cathinones and confers a distinct pharmacological profile. It appeared briefly in research chemical markets as a substituted cathinone with stimulant properties, though it has received far less attention than more established cathinones such as mephedrone or MDPV.
As with other substituted cathinones, 4-BMC produces stimulant effects through monoamine transporter interactions. However, the para-bromo substitution is associated with reduced potency at the dopamine transporter relative to serotonin transporters compared to its unsubstituted counterparts, potentially resulting in a profile with less intense euphoria and more prolonged serotonergic action. Community data on 4-BMC is limited, and the absence of formal clinical data means its toxicological profile must be inferred from structural analogy with the broader cathinone class.